Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD

Inhaled bronchodilators are central for the treatment of chronic obstructive pulmonary disease (COPD), as they can provide symptom relief and reduce the frequency and severity of exacerbations while improving health status and exercise tolerance. In 2017, glycopyrrolate (GLY) delivered via the eFlow...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashkin, Donald P., Niu, Xiaoli, Sharma, Sanjay, Sanjar, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497491/
https://www.ncbi.nlm.nih.gov/pubmed/34620878
http://dx.doi.org/10.1038/s41533-021-00255-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497491/
https://www.ncbi.nlm.nih.gov/pubmed/34620878
http://dx.doi.org/10.1038/s41533-021-00255-7

Ejemplares similares